See up to 3 months of PCVX. The 7-day demo opens the 1M and 3M ranges and puts PCVX on your watchlist.
Start 7-day demoLatest PCVX insider trades
About Vaxcyte, Inc. (PCVX)
The SEC lists Vaxcyte, Inc. under CIK 0001649094, in biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
PCVX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 21 | 92,890 | $6.32M |
| Grant or award | 2 | 140,886 | |
| Option exercise | 16 | 173,896 | |
PCVX insider transactions (Form 4)
9390 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jim Wassil - Officer | Option exercise | Common Stock | 18,000 | $5.35 | $96K | |
| Jim Wassil - Officer | Open-market sale | Common Stock | 18,000 | $86.74 | $1.56M | |
| Jim Wassil - Officer | Option exercise | Stock Option (right to buy) | 18,000 | $0.00 | - | |
| Elvia Cowan - Officer | Option exercise | Common Stock | 19,000 | $25.92 | $492K | |
| Elvia Cowan - Officer | Open-market sale | Common Stock | 19,000 | $86.74 | $1.65M | |
| Elvia Cowan - Officer | Option exercise | Stock Option (right to buy) | 19,000 | $0.00 | - | |
| Jim Wassil - Officer | Option exercise | Common Stock | 2,250 | $5.35 | $12K | |
| Jim Wassil - Officer | Open-market sale | Common Stock | 2,155 | $56.65 footnote F2 | $122K | |
| Jim Wassil - Officer | Open-market sale | Common Stock | 95 | $57.09 footnote F3 | $5K | |
| Jim Wassil - Officer | Option exercise | Stock Option (right to buy) | 2,250 | $0.00 | - | |
| ||||||
 Grant Pickering - Officer | Tax withholding / forfeiture | Common Stock | 17,056 footnote F1 | $60.36 | $1.03M | |
| ||||||
 Andrew Guggenhime - Officer | Tax withholding / forfeiture | Common Stock | 7,155 footnote F1 | $60.36 | $432K | |
| ||||||
| Harpreet S. Dhaliwal - Officer | Tax withholding / forfeiture | Common Stock | 7,651 footnote F1 | $60.36 | $462K | |
| ||||||
| Elvia Cowan - Officer | Tax withholding / forfeiture | Common Stock | 1,327 footnote F1 | $60.36 | $80K | |
| ||||||
| Jim Wassil - Officer | Open-market sale | Common Stock | 1,381 footnote F2 | $61.16 | $84K | |
| Jim Wassil - Officer | Tax withholding / forfeiture | Common Stock | 5,459 footnote F3 | $60.36 | $330K | |
| Jim Wassil - Officer | Open-market sale | Common Stock | 1,334 footnote F4 | $59.52 | $79K | |
| ||||||
| Luis Jodar - Officer | Grant or award | Common Stock | 52,632 footnote F1 | $0.00 | - | |
| Luis Jodar - Officer | Grant or award | Stock Option (right to buy) | 88,254 | $0.00 | - | |
| ||||||
| Jim Wassil - Officer | Tax withholding / forfeiture | Common Stock | 1,273 footnote F1 | $60.74 | $77K | |
| Jim Wassil - Officer | Option exercise | Common Stock | 2,250 | $5.35 | $12K | |
| Jim Wassil - Officer | Open-market sale | Common Stock | 1,537 | $60.89 footnote F3 | $94K | |
| Jim Wassil - Officer | Open-market sale | Common Stock | 713 | $61.48 footnote F4 | $44K | |
| Jim Wassil - Officer | Open-market sale | Common Stock | 924 | $60.96 footnote F5 | $56K | |
| Jim Wassil - Officer | Open-market sale | Common Stock | 303 | $61.42 footnote F6 | $19K | |
| Jim Wassil - Officer | Tax withholding / forfeiture | Common Stock | 1,432 footnote F1 | $61.58 | $88K | |
| Jim Wassil - Officer | Option exercise | Stock Option (right to buy) | 2,250 | $0.00 | - | |
| ||||||
| Grant Pickering - Officer | Tax withholding / forfeiture | Common Stock | 2,862 footnote F1 | $60.74 | $174K | |
| Grant Pickering - Officer | Tax withholding / forfeiture | Common Stock | 3,427 footnote F1 | $61.58 | $211K | |
| ||||||
| Andrew Guggenhime - Officer | Tax withholding / forfeiture | Common Stock | 1,273 footnote F1 | $60.74 | $77K | |
| Andrew Guggenhime - Officer | Tax withholding / forfeiture | Common Stock | 1,432 footnote F1 | $61.58 | $88K | |
| ||||||
| Harpreet S. Dhaliwal - Officer | Tax withholding / forfeiture | Common Stock | 361 footnote F1 | $60.74 | $22K | |
| Harpreet S. Dhaliwal - Officer | Tax withholding / forfeiture | Common Stock | 659 footnote F1 | $61.58 | $41K | |
| ||||||
| Elvia Cowan - Officer | Tax withholding / forfeiture | Common Stock | 243 footnote F1 | $60.74 | $15K | |
| Elvia Cowan - Officer | Tax withholding / forfeiture | Common Stock | 326 footnote F1 | $61.58 | $20K | |
| ||||||
| Harpreet S. Dhaliwal - Officer | Option exercise | Common Stock | 17,000 | $24.79 | $421K | |
| Harpreet S. Dhaliwal - Officer | Open-market sale | Common Stock | 17,000 | $55.00 footnote F3 | $935K | |
| Harpreet S. Dhaliwal - Officer | Option exercise | Stock Option (right to buy) | 17,000 | $0.00 | - | |
| ||||||
| Jim Wassil - Officer | Option exercise | Common Stock | 2,250 | $5.35 | $12K | |
| Jim Wassil - Officer | Open-market sale | Common Stock | 861 | $53.50 footnote F3 | $46K | |
| Jim Wassil - Officer | Open-market sale | Common Stock | 1,389 | $54.09 footnote F4 | $75K | |
| Jim Wassil - Officer | Option exercise | Stock Option (right to buy) | 2,250 | $0.00 | - | |
| ||||||
| Andrew Guggenhime - Officer | Option exercise | Common Stock | 10,000 | $5.35 | $54K | |
| Andrew Guggenhime - Officer | Open-market sale | Common Stock | 6,956 | $53.76 footnote F3 | $374K | |
| Andrew Guggenhime - Officer | Open-market sale | Common Stock | 3,044 | $54.18 footnote F4 | $165K | |
| Andrew Guggenhime - Officer | Option exercise | Stock Option (right to buy) | 10,000 | $0.00 | - | |
| ||||||
| Grant Pickering - Officer | Option exercise | Common Stock | 16,198 | $2.03 | $33K | |
| Grant Pickering - Officer | Open-market sale | Common Stock | 11,783 | $55.52 footnote F3 | $654K | |
| Grant Pickering - Officer | Open-market sale | Common Stock | 4,415 | $55.93 footnote F4 | $247K | |
| Grant Pickering - Officer | Open-market sale | Common Stock | 756 | $55.52 footnote F5 | $42K | |
| Grant Pickering - Officer | Open-market sale | Common Stock | 244 | $55.96 footnote F7 | $14K | |
| Grant Pickering - Officer | Open-market sale | Common Stock | 622 | $55.54 footnote F5 | $35K | |
| Grant Pickering - Officer | Open-market sale | Common Stock | 378 | $55.91 footnote F9 | $21K | |
| Grant Pickering - Officer | Option exercise | Stock Option (right to buy) | 16,198 | $0.00 | - | |
| ||||||
| John Markels - Director | Grant or award | Stock Option (right to buy) | 23,029 | $0.00 | - | |
| Andrew Guggenhime - Officer | Option exercise | Common Stock | 10,000 | $5.35 | $54K | |
| Andrew Guggenhime - Officer | Open-market sale | Common Stock | 7,913 | $57.16 footnote F2 | $452K | |
| Andrew Guggenhime - Officer | Open-market sale | Common Stock | 2,087 | $57.76 footnote F3 | $121K | |
| Andrew Guggenhime - Officer | Option exercise | Stock Option (right to buy) | 10,000 | $0.00 | - | |
| ||||||
| Jim Wassil - Officer | Option exercise | Common Stock | 516 | $5.35 | $3K | |
| Jim Wassil - Officer | Open-market sale | Common Stock | 1,788 | $56.03 footnote F2 | $100K | |
| Jim Wassil - Officer | Open-market sale | Common Stock | 456 | $57.47 footnote F3 | $26K | |
| Jim Wassil - Officer | Open-market sale | Common Stock | 6 | $57.82 | $347 | |
| Jim Wassil - Officer | Option exercise | Stock Option (right to buy) | 516 | $0.00 | - | |
| ||||||
| Grant Pickering - Officer | Open-market sale | Common Stock | 6,417 | $56.12 footnote F4 | $360K | |
| Grant Pickering - Officer | Open-market sale | Common Stock | 312 | $54.35 footnote F5 | $17K | |
| Grant Pickering - Officer | Open-market sale | Common Stock | 356 | $55.23 footnote F7 | $20K | |
| Grant Pickering - Officer | Open-market sale | Common Stock | 332 | $55.99 footnote F8 | $19K | |
| Grant Pickering - Officer | Open-market sale | Common Stock | 207 | $54.22 footnote F9 | $11K | |
| Grant Pickering - Officer | Open-market sale | Common Stock | 602 | $55.30 footnote F11 | $33K | |
| Grant Pickering - Officer | Open-market sale | Common Stock | 191 | $56.27 footnote F12 | $11K | |
| Grant Pickering - Officer | Open-market sale | Common Stock | 6,683 | $54.28 footnote F2 | $363K | |
| Grant Pickering - Officer | Open-market sale | Common Stock | 9,137 | $55.27 footnote F3 | $505K | |
| ||||||
| Moncef Slaoui - Director | Grant or award | Stock Option (right to buy) | 26,061 | $0.00 | - | |
| Grant Pickering - Officer | Open-market sale | Common Stock | 1,000 | $52.50 | $53K | |
| Grant Pickering - Officer | Open-market sale | Common Stock | 1,000 | $52.50 | $53K | |
| Grant Pickering - Officer | Option exercise | Stock Option (right to buy) | 225 | $0.00 | - | |
| Grant Pickering - Officer | Option exercise | Common Stock | 225 | $1.79 | $403 | |
| Grant Pickering - Officer | Open-market sale | Common Stock | 225 | $52.51 | $12K | |
| Grant Pickering - Officer | Open-market sale | Common Stock | 22,236 | $52.50 | $1.17M | |
| Andrew Guggenhime - Officer | Option exercise | Common Stock | 10,000 | $5.35 | $54K | |
| Andrew Guggenhime - Officer | Open-market sale | Common Stock | 10,000 | $53.00 | $530K | |
| Andrew Guggenhime - Officer | Option exercise | Stock Option (right to buy) | 10,000 | $0.00 | - | |
| Carlos V. Paya - Director | Grant or award | Common Stock | 2,265 footnote F1 | $0.00 | - | |
| Carlos V. Paya - Director | Grant or award | Stock Option (right to buy) | 11,389 | $0.00 | - | |
| ||||||
| Olivier Brandicourt - Director | Grant or award | Common Stock | 2,194 footnote F1 | $0.00 | - | |
| Olivier Brandicourt - Director | Grant or award | Stock Option (right to buy) | 11,034 | $0.00 | - | |
| ||||||
 John Furey - Director | Grant or award | Common Stock | 2,265 footnote F1 | $0.00 | - | |
| John Furey - Director | Grant or award | Stock Option (right to buy) | 11,389 | $0.00 | - | |
| ||||||
| Jacks Lee - Director | Grant or award | Stock Option (right to buy) | 11,389 | $0.00 | - | |
| Jacks Lee - Director | Grant or award | Common Stock | 2,265 footnote F1 | $0.00 | - | |
| ||||||
| Halley E. Gilbert - Director | Grant or award | Common Stock | 2,265 footnote F1 | $0.00 | - | |
| Halley E. Gilbert - Director | Grant or award | Stock Option (right to buy) | 11,389 | $0.00 | - | |
| ||||||
Item 1.01, 2.03, 8.01, 9.01
Item 7.01, 8.01, 9.01
Item 5.02, 7.01, 9.01
Item 2.02, 9.01
Recent PCVX Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Cowan Elvia | Officer | 19,000 | $1.65M | View on EDGAR | |
| Wassil Jim | Officer | 18,000 |
Stock trades in PCVX disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
 Gilbert Ray Cisneros, Jr.Democrat, CA-31 | Purchase |
PCVX insider trading FAQ
What is the latest insider trade for PCVX?
Vaxcyte, Inc. (PCVX) had 18 insider filings in the last 90 days, with the most recent on 2026-10-07. The full record for PCVX runs to 90 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying PCVX stock?
No insider purchases of PCVX were filed in the last 90 days.
How many insiders are selling PCVX stock?
21 insider sales of PCVX were filed in the last 90 days, totaling $6.32M.
Where can I see PCVX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects PCVX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Jim Wassil view on EDGAR
- - Elvia Cowan view on EDGAR
- - Jim Wassil view on EDGAR
- - Grant Pickering view on EDGAR
- - Andrew Guggenhime view on EDGAR
- - Harpreet S. Dhaliwal view on EDGAR
- - Elvia Cowan view on EDGAR
- - Jim Wassil view on EDGAR
- - Luis Jodar view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where PCVX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow PCVX with a 7-day demo
- PCVX on your watchlist
- Every PCVX Form 4 filing on record
- Up to 3 months of PCVX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
